Qualitative and quantitative issues of lymph nodes as prognostic factor in colon cancer

Digestive Surgery

Volumn 30, Issue 1, 2013, Pages 1-11

  Veen, Torhild ^a   Nedrebø, Bjørn S ^a   Stormark, Kjartan ^a   Søreide, Jon Arne ^a,b   Kørner, Hartwig ^a,b   Søreide, Kjetil ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Colon cancer; Lymph nodes; Molecular biology; Pathology; Quality; Sampling; Sentinel node; Staging; Surgery; Volume

Indexed keywords

COLONIC NEOPLASMS; HUMAN; LYMPH NODE METASTASIS; PATHOLOGY; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

COLONIC NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 84876089900     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000349923     Document Type: Review

References (107)

1. Nedrebø BS, Søreide K, Eriksen MT, Dorum LM, Kvaløy JT, Søreide JA, Kørner H: Survival effect of implementing national treatment strategies for curatively resected colonic and rectal cancer. Br J Surg 2011; 98: 716-723
2. Søreide K, Berg M, Skudal BS, Nedreboe BS: Advances in the understanding and treatment of colorectal cancer. Discov Med 2011; 12: 393-404
3. Søreide K, Nedrebø BS, Knapp JC, Glomsaker TB, Søreide JA, Kørner H: Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: Potential implications for the surgical oncologist. Surg Oncol 2009; 18: 31-50
4. Berg M, Søreide K: Genetic and epigenetic traits as biomarkers in colorectal cancer. Int J Mol Sci 2011; 12: 9426-9439
5. Compton CC, Greene FL: The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 2004; 54: 295-308
6. Nedrebø BS, Søreide K, Eriksen MT, Kvaløy JT, Søreide JA, Kørner H: Excess mortality after curative surgery for colorectal cancer changes over time and differs for patients with colon versus rectal cancer. Acta Oncol 2012, E-pub ahead of print
7. Shia J, Wang H, Nash GM, Klimstra DS: Lymph node staging in colorectal cancer: Revisiting the benchmark of at least 12 lymph nodes in r0 resection. J Am Coll Surg 2012; 214: 348-355
8. McDonald JR, Renehan AG, O'Dwyer ST, Haboubi NY: Lymph node harvest in colon and rectal cancer: Current considerations. World J Gastrointest Surg 2012; 4: 9-19
9. Aslani N, Lobo-Prabhu K, Heidary B, Phang T, Raval MJ, Brown CJ: Outcomes of laparoscopic colon cancer surgery in a population-based cohort in British Columbia: Are they as good as the clinical trials? Am J Surg 2012; 204: 411-415
10. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA: Lymph node evaluation and survival after curative resection of colon cancer: Systematic review. J Natl Cancer Inst 2007; 99: 433-441
11. Bernhoff R, Holm T, Sjovall A, Granath F, Ekbom A, Martling A: Increased lymph node harvest in patients operated on for right-sided colon cancer: A population-based study. Colorectal Dis 2012; 14: 691-696
12. Parsons HM, Tuttle TM, Kuntz KM, Begun JW, McGovern PM, Virnig BA: Association between lymph node evaluation for colon cancer and node positivity over the past 20 years. JAMA 2011; 306: 1089-1097
13. Stojadinovic A, Nissan A, Wainberg Z, Shen P, McCarter M, Protic M, Howard RS, Steele SR, Peoples GE, Bilchik A: Time-dependent trends in lymph node yield and impact on adjuvant therapy decisions in colon cancer surgery: An international multi-institutional study. Ann Surg Oncol 2012; 19: 4178- 4185
14. Parsons HM, Tuttle TM, Kuntz KM, Begun JW, McGovern PM, Virnig BA: Quality of care along the cancer continuum: Does receiving adequate lymph node evaluation for colon cancer lead to comprehensive postsurgical care? J Am Coll Surg 2012; 215: 400-411
15. Ceelen W, Van Nieuwenhove Y, Pattyn P: Prognostic value of the lymph node ratio in stage III colorectal cancer: A systematic review. Ann Surg Oncol 2010; 17: 2847-2855
16. Chang YJ, Chang YJ, Chen LJ, Chung KP, Lai MS: Evaluation of lymph nodes in patients with colon cancer undergoing colon resection: A population-based study. World J Surg 2012; 36: 1906-1914
17. Ogino S, Nosho K, Irahara N, Shima K, Baba Y, Kirkner GJ, Mino-Kenudson M, Giovannucci EL, Meyerhardt JA, Fuchs CS: Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction. Am J Gastroenterol 2010; 105: 420-433
18. Danko ME, Bennett KM, Zhai J, Marks JR, Olson JA Jr: Improved staging in node-positive breast cancer patients using lymph node ratio: Results in 1,788 patients with long-Term follow- up. J Am Coll Surg 2010; 210: 797-805.e1, 805-807
19. Vaccaro CA, Im V, Rossi GL, Quintana GO, Benati ML, Perez de Arenaza D, Bonadeo FA: Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons. Dis Colon Rectum 2009; 52: 1244-1250
20. Park IJ, Choi GS, Jun SH: Nodal stage of stage III colon cancer: The impact of metastatic lymph node ratio. J Surg Oncol 2009; 100: 240-243
21. Chin CC, Wang JY, Yeh CY, Kuo YH, Huang WS, Yeh CH: Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer. Int J Colorectal Dis 2009; 24: 1297-1302
22. Wang J, Hassett JM, Dayton MT, Kulaylat MN: Lymph node ratio: Role in the staging of node-positive colon cancer. Ann Surg Oncol 2008; 15: 1600-1608
23. Telian SH, Bilchik AJ: Significance of the lymph node ratio in stage III colon cancer. Ann Surg Oncol 2008; 15: 1557-1558
24. Derwinger K, Carlsson G, Gustavsson B: A study of lymph node ratio as a prognostic marker in colon cancer. Eur J Surg Oncol 2008; 34: 771-775
25. De Ridder M, Vinh-Hung V, Van Nieuwenhove Y, Hoorens A, Sermeus A, Storme G: Prognostic value of the lymph node ratio in node positive colon cancer. Gut 2006; 55: 1681
26. Lykke J, Roikjaer O, Jess P, Danish Colorectal Cancer Group: The relation between lymph node status and survival in stage I-III colon cancer: Results from a prospective nationwide cohort study. Colorectal Dis 2012, E-pub ahead of print
27. Sjo OH, Merok MA, Svindland A, Nesbakken A: Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer. Dis Colon Rectum 2012; 55: 307-315
28. Hong KD, Lee SI, Moon HY: Lymph node ratio as determined by the 7th edition of the American Joint Committee on Cancer staging system predicts survival in stage III colon cancer. J Surg Oncol 2011; 103: 406-410
29. Persiani R, Cananzi FC, Biondi A, Paliani G, Tufo A, Ferrara F, Vigorita V, D'Ugo D: Log odds of positive lymph nodes in colon cancer: A meaningful ratio-based lymph node classification system. World J Surg 2012; 36: 667-674
30. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG: Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 2005; 23: 8706-8712
31. Sinan H, Demirbas S, Ersoz N, Ozerhan IH, Yagci G, Akyol M, Cetiner S: Who is responsible for inadequate lymph node retrieval after colorectal surgery: Surgeon or pathologist? Acta Chir Belg 2012; 112: 200-208
32. Kuijpers CC, van Slooten HJ, Schreurs WH, Moormann GR, Abtahi MA, Slappendel A, Cliteur V, van Diest PJ, Jiwa NM: Better retrieval of lymph nodes in colorectal resection specimens by pathologists' assistants. J Clin Pathol 2013; 66: 18-23
33. Frasson M, Faus C, Garcia-Granero A, Puga R, Flor-Lorente B, Cervantes A, Navarro S, Garcia-Granero E: Pathological evaluation of mesocolic resection quality and ex vivo methylene blue injection: What is the impact on lymph node harvest after colon resection for cancer? Dis Colon Rectum 2012; 55: 197-204
34. Mekenkamp LJ, van Krieken JH, Marijnen CA, van de Velde CJ, Nagtegaal ID: Lymph node retrieval in rectal cancer is dependent on many factors-The role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol 2009; 33: 1547- 1553
35. Bilchik AJ, Compton C: Close collaboration between surgeon and pathologist is essential for accurate staging of early colon cancer. Ann Surg 2007; 245: 864-866
36. Mathoulin-Pelissier S, Becouarn Y, Belleannee G, Pinon E, Jaffre A, Coureau G, Auby D, Renaud-Salis JL, Rullier E: Quality indicators for colorectal cancer surgery and care according to patient-, tumor-, and hospital-related factors. BMC Cancer 2012; 12: 297
37. Parsons HM, Begun JW, McGovern PM, Tuttle TM, Kuntz KM, Virnig BA: Hospital characteristics associated with maintenance or im provement of guideline-recommended lymph node evaluation for colon cancer. Med Care 2013; 51: 60-67
38. Nedrebø BS, Søreide K, Nesbakken A, Tandberg Eriksen M, Søreide JA, Kørner H: Assessment of risk factors associated with poor lymph node harvest after colon cancer surgery in a national cohort. Colorectal Dis 2013, in press
39. Hsieh MC, Velasco C, Wu XC, Pareti LA, Andrews PA, Chen VW: Influence of socioeconomic status and hospital type on disparities of lymph node evaluation in colon cancer patients. Cancer 2012; 118: 1675-1683
40. Archampong D, Borowski D, Wille-Jorgensen P, Iversen LH: Workload and surgeon's specialty for outcome after colorectal cancer surgery. Cochrane Database Syst Rev 2012; 3:CD005391
41. Luglio G, Nelson H: Laparoscopy for colon cancer: State of the art. Surg Oncol Clin N Am 2010; 19: 777-791
42. Wu Z, Zhang S, Aung LH, Ouyang J, Wei L: Lymph node harvested in laparoscopic versus open colorectal cancer approaches: A metaanalysis. Surg Laparosc Endosc Percutan Tech 2012; 22: 5-11
43. Mathis KL, Green EM, Sargent DJ, Delaney C, Simmang CL, Nelson H: Surgical quality surrogates do not predict colon cancer survival in the setting of technical credentialing: A report from the prospective COST trial. Ann Surg 2013; 257: 102-107
44. West NP, Hohenberger W, Weber K, Perrakis A, Finan PJ, Quirke P: Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol 2010; 28: 272-278
45. West NP, Kobayashi H, Takahashi K, Perrakis A, Weber K, Hohenberger W, Sugihara K, Quirke P: Understanding optimal colonic cancer surgery: Comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol 2012; 30: 1763-1769
46. Weber K, Merkel S, Perrakis A, Hohenberger W: Is there a disadvantage to radical lymph node dissection in colon cancer? Int J Colorectal Dis 2013; 28: 217-226
47. Bertelsen CA, Bols B, Ingeholm P, Jansen JE, Neuenschwander AU, Vilandt J: Can the quality of colonic surgery be improved by standardization of surgical technique with complete mesocolic excision? Colorectal Dis 2011; 13: 1123-1129
48. Gouvas N, Pechlivanides G, Zervakis N, Kafousi M, Xynos E: Complete mesocolic excision in colon cancer surgery: A comparison between open and laparoscopic approach. Colorectal Dis 2012; 14: 1357-1364
49. Feng B, Sun J, Ling TL, Lu AG, Wang ML, Chen XY, Ma JJ, Li JW, Zang L, Han DP, Zheng MH: Laparoscopic complete mesocolic excision (CME) with medial access for righthemi colon cancer: Feasibility and technical strategies. Surg Endosc 2012; 26: 3669-3675
50. Titu LV, Tweedle E, Rooney PS: High tie of the inferior mesenteric artery in curative surgery for left colonic and rectal cancers: A systematic review. Dig Surg 2008; 25: 148-157
51. Cirocchi R, Trastulli S, Farinella E, Desiderio J, Vettoretto N, Parisi A, Boselli C, Noya G: High tie versus low tie of the inferior mesenteric artery in colorectal cancer: A RCT is needed. Surg Oncol 2012; 21:e111-e123
52. Hogan AM, Winter DC: Mesocolic plane surgery: A reliable benchmark of surgical excellence? Int J Colorectal Dis 2010; 25: 291
53. Hogan AM, Winter DC: Mesocolic plane surgery: Just plain surgery? Colorectal Dis 2009; 11: 430-431
54. Casati B, Bjugn R: Structured electronic template for histopathology reporting on colorectal carcinoma resections: Five-year follow-up shows sustainable long-Term quality improvement. Arch Pathol Lab Med 2012; 136: 652-656
55. Siriwardana PN, Pathmeswaran A, Hewavisenthi J, Deen KI: Histopathology reporting in colorectal cancer: A proforma improves quality. Colorectal Dis 2009; 11: 849-853
56. Bjugn R, Casati B, Norstein J: Structured electronic template for histopathology reports on colorectal carcinomas: A joint project by the cancer registry of Norway and the Norwegian society for pathology. Hum Pathol 2008; 39: 359-367
57. Haugland HK, Casati B, Dorum LM, Bjugn R: Template reporting matters-A nationwide study on histopathology reporting on colorectal carcinoma resections. Hum Pathol 2011; 42: 36-40
58. Srigley JR, McGowan T, Maclean A, Raby M, Ross J, Kramer S, Sawka C: Standardized synoptic cancer pathology reporting: A population- based approach. J Surg Oncol 2009; 99: 517-524
59. Buchwald P, Olofsson F, Lorinc E, Syk I: Standard protocol for assessment of colon cancer improves the quality of pathology. Colorectal Dis 2011; 13:e33-e36
60. Valsecchi ME, Leighton J Jr, Tester W: Modifiable factors that influence colon cancer lymph node sampling and examination. Clin Colorectal Cancer 2010; 9: 162-167
61. Galvis CO, Raab SS, D'Amico F, Grzybicki DM: Pathologists' assistants practice: A measurement of performance. Am J Clin Pathol 2001; 116: 816-822
62. Reese JA, Hall C, Bowles K, Moesinger RC: Colorectal surgical specimen lymph node harvest: Improvement of lymph node yield with a pathology assistant. J Gastrointest Surg 2009; 13: 1459-1463
63. Vitale J, Brooks R, Sovocool M, Rader WR: Value-Added benefits and utilization of pathologists' assistants. Arch Pathol Lab Med 2012; 136: 1565-1570
64. Svec A, Horak L, Novotny J, Lysy P: Re-fixation in a lymph node revealing solution is a powerful method for identifying lymph nodes in colorectal resection specimens. Eur J Surg Oncol 2006; 32: 426-429
65. Lindboe CF: Lymph node harvest in colorectal adenocarcinoma specimens: The impact of improved fixation and examination procedures. APMIS 2011; 119: 347-355
66. Iversen LH, Laurberg S, Hagemann-Madsen R, Dybdahl H: Increased lymph node harvest from colorectal cancer resections using GEWF solution: A randomised study. J Clin Pathol 2008; 61: 1203-1208
67. Gregurek SF, Wu HH: Can GEWF solution improve the retrieval of lymph nodes from colorectal cancer resections? Arch Pathol Lab Med 2009; 133: 83-86
68. Newell KJ, Sawka BW, Rudrick BF, Driman DK: GEWF solution. Arch Pathol Lab Med 2001; 125: 642-645
69. Tasi CK, Chen CY, Liu CY, Wu YY: Reliability and effectiveness of GEWF solution in the identification of lymph nodes in specimens of colorectal carcinoma. Int J Surg Pathol 2012; 20: 589-595
70. van der Zaag ES, Bouma WH, Peters HM, Bemelman WA, Buskens CJ: Implications of sentinel lymph node mapping on nodal staging and prognosis in colorectal cancer. Colorectal Dis 2012; 14: 684-690
71. Wasif N, Faries MB, Saha S, Turner RR, Wiese D, McCarter MD, Shen P, Stojadinovic A, Bilchik AJ: Predictors of occult nodal metastasis in colon cancer: Results from a prospective multicenter trial. Surgery 2010; 147: 352- 357
72. Stojadinovic A, Nissan A, Protic M, Adair CF, Prus D, Usaj S, Howard RS, Radovanovic D, Breberina M, Shriver CD, Grinbaum R, Nelson JM, Brown TA, Freund HR, Potter JF, Peretz T, Peoples GE: Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: Results from the United States Military Cancer Institute Clinical Trials Group study GI-01. Ann Surg 2007; 245: 846-857
73. Güller U, Zettl A, Worni M, Langer I, Cabalzar- Wondberg D, Viehl CT, Demartines N, Zuber M: Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): A new road to better staging? Cancer 2012; 118: 6039-6045
74. Leong SP: Paradigm of metastasis for melanoma and breast cancer based on the sentinel lymph node experience. Ann Surg Oncol 2004; 11: 192S-197S.
75. Scoggins CR, Chagpar AB, Martin RC, Mc- Masters KM: Should sentinel lymph-node biopsy be used routinely for staging melanoma and breast cancers? Nat Clin Pract Oncol 2005; 2: 448-455
76. Nordgard O, Oltedal S, Aasprong OG, Søreide JA, Søreide K, Tjensvoll K, Gilje B, Heikkila R, Guriby M, Lothe RA, Smaaland R, Korner H: Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 MRNA levels in sentinel lymph nodes from colon cancer patients. Ann Surg Oncol 2012; 19: 3719-3726
77. de Haas RJ, Wicherts DA, Hobbelink MG, van Diest PJ, Vleggaar FP, Borel Rinkes IH, van Hillegersberg R: Sentinel lymph node mapping in colon cancer using radiocolloid as a single tracer: A feasibility study. Nucl Med Commun 2012; 33: 832-837
78. van der Zaag ES, Bouma WH, Tanis PJ, Ubbink DT, Bemelman WA, Buskens CJ: Systematic review of sentinel lymph node mapping procedure in colorectal cancer. Ann Surg Oncol 2012; 19: 3449-3459
79. van der Pas MH, Meijer S, Hoekstra OS, Riphagen II, de Vet HC, Knol DL, van Grieken NC, Meijerink WJ: Sentinel-lymph-node procedure in colon and rectal cancer: A systematic review and meta-Analysis. Lancet Oncol 2011; 12: 540-550
80. Viehl CT, Güller U, Cecini R, Langer I, Ochsner A, Terracciano L, Riehle HM, Laffer U, Oertli D, Zuber M: Sentinel lymph node procedure leads to upstaging of patients with resectable colon cancer: Results of the Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer. Ann Surg Oncol 2012; 19: 1959-1965
81. Rahbari NN, Bork U, Motschall E, Thorlund K, Buchler MW, Koch M, Weitz J: Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: A systematic review and meta-Analysis. J Clin Oncol 2012; 30: 60-70
82. Chang GJ, Kaiser AM, Mills S, Rafferty JF, Buie WD: Practice parameters for the management of colon cancer. Dis Colon Rectum 2012; 55: 831-843
83. Bertagnolli M, Miedema B, Redston M, Dowell J, Niedzwiecki D, Fleshman J, Bem J, Mayer R, Zinner M, Compton C: Sentinel node staging of resectable colon cancer: Results of a multicenter study. Ann Surg 2004; 240: 624- 628; discussion 628-630
84. Steele SR, Chen SL, Stojadinovic A, Nissan A, Zhu K, Peoples GE, Bilchik A: The impact of age on quality measure adherence in colon cancer. J Am Coll Surg 2011; 213: 95-103; discussion 104-105
85. Shibakita M, Yoshimura H, Tachibana M, Ueda S, Nagasue N: Body mass index influences long-Term outcome in patients with colorectal cancer. Hepatogastroenterology 2010; 57: 62-69
86. Kuo YH, Lee KF, Chin CC, Huang WS, Yeh CH, Wang JY: Does body mass index impact the number of LNS harvested and influence long-Term survival rate in patients with stage III colon cancer? Int J Colorectal Dis 2012; 27: 1625-1635
87. Nowaczyk P, Murawa D, Polom K, Waszyk- Nowaczyk M, Spychala A, Michalak M, Murawa P: Analysis of sentinel lymph node biopsy results in colon cancer in regard of the anthropometric features of the population and body composition assessment formulas. Langenbecks Arch Surg 2012; 397: 779-786
88. Brandstedt J, Wangefjord S, Nodin B, Gaber A, Manjer J, Jirstrom K: Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: A cohort study. Biol Sex Differ 2012; 3: 23
89. Bamboat ZM, Kinnier C, Dursun A, Ferrone CR, Shellito PC, Berger DL, Bordeianou L: Short-Term outcomes in obese patients after colectomy for adenocarcinoma at a bariatric center. J Gastrointest Surg 2012; 16: 1923-1928
90. Merok MA, Ahlquist T, Royrvik EC, Tufteland KF, Hektoen M, Sjo OH, Mala T, Svindland A, Lothe RA, Nesbakken A: Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: Results from a large, consecutive Norwegian series. Ann Oncol 2012, E-pub ahead of print
91. Chou JF, Row D, Gonen M, Liu YH, Schrag D, Weiser MR: Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: A populationbased study. Cancer 2010; 116: 2560-2570
92. Bilimoria KY, Palis B, Stewart AK, Bentrem DJ, Freel AC, Sigurdson ER, Talamonti MS, Ko CY: Impact of tumor location on nodal evaluation for colon cancer. Dis Colon Rectum 2008; 51: 154-161
93. Powell AG, Wallace R, McKee RF, Anderson JH, Going JJ, Edwards J, Horgan PG: The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer. Colorectal Dis 2012; 14: 1493-1499
94. Richards CH, Leitch EF, Horgan PG, Anderson JH, McKee RF, McMillan DC: The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer. Br J Cancer 2010; 103: 1356- 1361
95. Berg M, Søreide K: EGFR and downstream genetic alterations in KRAS/BRAF and PI3K/AKT pathways in colorectal cancer-implications for targeted therapy. Discov Med 2012; 14: 207-214
96. Søreide K: High-fidelity of five quasimonomorphic mononucleotide repeats to highfrequency microsatellite instability distribution in early-stage adenocarcinoma of the colon. Anticancer Res 2011; 31: 967-971
97. Søreide K, Nedrebø BS, Søreide JA, Slewa A, Kørner H: Lymph node harvest in colon cancer: Influence of microsatellite instability and proximal tumor location. World J Surg 2009; 33: 2695-2703
98. Belt EJ, te Velde EA, Krijgsman O, Brosens RP, Tijssen M, van Essen HF, Stockmann HB, Bril H, Carvalho B, Ylstra B, Bonjer HJ, Meijer GA: High lymph node yield is related to microsatellite instability in colon cancer. Ann Surg Oncol 2012; 19: 1222-1230
99. Eveno C, Nemeth J, Soliman H, Praz F, de The H, Valleur P, Talbot IC, Pocard M: Association between a high number of isolated lymph nodes in T1 to T4 N0M0 colorectal cancer and the microsatellite instability phenotype. Arch Surg 2010; 145: 12-17
100. MacQuarrie E, Arnason T, Gruchy J, Yan S, Drucker A, Huang WY: Microsatellite instability status does not predict total lymph node or negative lymph node retrieval in stage III colon cancer. Hum Pathol 2012; 43: 1258-1264
101. Senthil M, Trisal V, Paz IB, Lai LL: Prediction of the adequacy of lymph node retrieval in colon cancer by hospital type. Arch Surg 2010; 145: 840-843
102. Hladik P, Vizda J, Bedrna J, Simkovic D, Strnad L, Smejkal K, Voboril Z: Immunoscintigraphy and intra-operative radioimmunodetection in the treatment of colorectal carcinoma. Colorectal Dis 2001; 3: 380-386
103. Gu J, Zhao J, Li Z, Yang Z, Zhang J, Gao Z, Wang Y, Xu G: Clinical application of radioimmunoguided surgery in colorectal cancer using 125i-labeled carcinoembryonic antigen- specific monoclonal antibody submucosally. Dis Colon Rectum 2003; 46: 1659-1666
104. Kim JC, Roh SA, Koo KH, Cho YK, Kim HC, Yu CS, Oh SJ, Ryu JS, Bicknell DC, Bodmer WF: Preclinical application of radioimmunoguided surgery using anti-carcinoembryonic antigen biparatopic antibody in the colon cancer. Eur Surg Res 2005; 37: 36-44
105. Sun D, Bloomston M, Hinkle G, Al-Saif OH, Hall NC, Povoski SP, Arnold MW, Martin EW Jr: Radioimmunoguided surgery (RIGS), PET/CT image-guided surgery, and fluorescence image-guided surgery: Past, present, and future. J Surg Oncol 2007; 96: 297-308
106. Artiko VM, Sobic-Saranovic DP, Krivokapic ZV, Petrovic MN, Obradovic VB: Is there a future role for immunoscintigraphy in the diagnosis of colorectal carcinoma? Neoplasma 2009; 56: 1-8.
107. Tiernan JP, Ansari I, Hirst NA, Millner PA, Hughes TA, Jayne DG: Intra-operative tumour detection and staging in colorectal cancer surgery. Colorectal Dis 2012; 14: E510-e520